Published in Gene Therapy Weekly, August 9th, 2001
Patients stricken by liver cancers caused by viral hepatitis, liver toxins, or cirrhosis could potentially benefit from the gene transfer system, which uses a receptor-mediated delivery mechanism to transfer tumor suppressor genes directly to liver cancer cells.
"For gene therapy to be effective in cancers, it is necessary to deliver therapeutic genes into cells with high specificity and efficiency," commented Terence Kin-Wah Lee and colleagues, University of Hong Kong.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.